Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment
In contrast, certain studies and reports have indicated that there were not any significant differences between general perioperative adverse outcomes (Raven et al
Almond pastries are perhaps the most iconic dessert, made with ground almonds, sugar and egg whites, and flavoured with lemon peel or bitter almond essence
Speak with a primary care provider.